Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15265272rdf:typepubmed:Citationlld:pubmed
pubmed-article:15265272lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:15265272lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:15265272lifeskim:mentionsumls-concept:C0699748lld:lifeskim
pubmed-article:15265272lifeskim:mentionsumls-concept:C0599708lld:lifeskim
pubmed-article:15265272lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:15265272lifeskim:mentionsumls-concept:C0598411lld:lifeskim
pubmed-article:15265272lifeskim:mentionsumls-concept:C0598413lld:lifeskim
pubmed-article:15265272lifeskim:mentionsumls-concept:C1554080lld:lifeskim
pubmed-article:15265272lifeskim:mentionsumls-concept:C1706198lld:lifeskim
pubmed-article:15265272lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:15265272pubmed:issue5lld:pubmed
pubmed-article:15265272pubmed:dateCreated2004-7-21lld:pubmed
pubmed-article:15265272pubmed:abstractTextNitric oxide (NO) is a short-life key bioregulatory active molecule in the cardiovascular, immune and nervous systems. NO is synthesized by converting L-arginine to L-citrulline by enzymes called NO synthase (NOS). The growing body of evidence strongly supports the theory that this molecule appears to be one of the key targets for the disruption of normal brain homeostasis, which causes the development of brain lesions and pathology such as in Alzheimer's disease (AD) or other related dementia. The vascular content of NO activity appears especially to be a main contributor to this pathology before the over-expression of other NOS isoforms activity in a different brain cellular compartment. We speculate that pharmacological intervention using NO donors and/or NO suppressors will be able to delay or minimize the development of brain pathology and further progression of mental retardation.lld:pubmed
pubmed-article:15265272pubmed:languageenglld:pubmed
pubmed-article:15265272pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15265272pubmed:citationSubsetIMlld:pubmed
pubmed-article:15265272pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15265272pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15265272pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15265272pubmed:statusMEDLINElld:pubmed
pubmed-article:15265272pubmed:monthJullld:pubmed
pubmed-article:15265272pubmed:issn0161-6412lld:pubmed
pubmed-article:15265272pubmed:authorpubmed-author:SmithMark AMAlld:pubmed
pubmed-article:15265272pubmed:authorpubmed-author:PerryGeorgeGlld:pubmed
pubmed-article:15265272pubmed:authorpubmed-author:AlievGjumrakc...lld:pubmed
pubmed-article:15265272pubmed:authorpubmed-author:LambBruce TBTlld:pubmed
pubmed-article:15265272pubmed:authorpubmed-author:de la...lld:pubmed
pubmed-article:15265272pubmed:authorpubmed-author:ChenShu GSGlld:pubmed
pubmed-article:15265272pubmed:authorpubmed-author:ObrenovichMar...lld:pubmed
pubmed-article:15265272pubmed:authorpubmed-author:SeyidovaDilar...lld:pubmed
pubmed-article:15265272pubmed:authorpubmed-author:AliyevAliAlld:pubmed
pubmed-article:15265272pubmed:authorpubmed-author:RzayevNizamiNlld:pubmed
pubmed-article:15265272pubmed:issnTypePrintlld:pubmed
pubmed-article:15265272pubmed:volume26lld:pubmed
pubmed-article:15265272pubmed:ownerNLMlld:pubmed
pubmed-article:15265272pubmed:authorsCompleteYlld:pubmed
pubmed-article:15265272pubmed:pagination547-53lld:pubmed
pubmed-article:15265272pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:meshHeadingpubmed-meshheading:15265272...lld:pubmed
pubmed-article:15265272pubmed:year2004lld:pubmed
pubmed-article:15265272pubmed:articleTitleIs nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease?lld:pubmed
pubmed-article:15265272pubmed:affiliationMicroscopy Research Center, Case Western Reserve University, Cleveland, OH 44106, USA.lld:pubmed
pubmed-article:15265272pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15265272pubmed:publicationTypeReviewlld:pubmed
pubmed-article:15265272pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15265272lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15265272lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15265272lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15265272lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15265272lld:pubmed